Martin M.; Zielinski C.; Ruiz-Borrego M.; Carrasco E.; Turner N.; Ciruelos E. M.; Muñoz M.; Bermejo B.; Margeli M.; Anton A.; Kahán Zsuzsanna; Csöszi Tibor; Casas M. I.; Murillo L.; Morales S.:
Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL.
ANNALS OF ONCOLOGY, 32 (4).
pp. 488-499.
ISSN 0923-7534
(2021)